White blood cell count is associated with plasma total homocysteine in Japanese men

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 65, Issue 6, 2005, Pages 447-452

  Sakuta, Hidenari ^a,b   Suzuki, T ^a   Yasuda, H ^a   Ito, T ^a  

^a Self Defense Forces Central Hospital   (Japan)

^b GSDF Medical School   (Japan)

Author keywords

glutamyl transferase; Cardiovascular disease; Homocysteine; Risk factor; White blood cell count

Indexed keywords

ALCOHOL; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HOMOCYSTEINE; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; DIETARY INTAKE; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; JAPAN; LEUKOCYTE COUNT; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; VEGETABLE;

CARDIOVASCULAR DISEASES; GAMMA-GLUTAMYLTRANSFERASE; HOMOCYSTEINE; HUMANS; JAPAN; LEUKOCYTE COUNT; MALE; MIDDLE AGED; RISK FACTORS;

EID: 27144544158     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510510025782     Document Type: Article

References (28)

1. Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count as a predictor of myocardial infarction. N Engl J Med 1974;290:1275-8.
2. Grimm RH Jr, Neaton JD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. J Am Med Assoc 1985;254:1932-7.
3. de Labry LO, Campion EW, Glynn RJ, Vokonas PS. White blood cell count as a predictor of mortality: results over 18 years from the Normative Aging Study. J Clin Epidemiol 1990;43:153-7.
4. Sweetnam PM, Thomas HF, Yarnell JW, Baker IA, Elwood PC. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. Am J Epidemiol 1997;145:416-21.
5. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease. J Am Med Assoc 1998;279:1477-82.
6. Brown DW, Giles WH, Croft JB. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol 2001;54:316-22.
7. Lee CD, Folsom AR, Nieto FJ, Chambless LE, Shahar E, Wolfe DA. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities study. Am J Epidemiol 2001;154: 758-64.
8. Corre F, Lellouch J, Schwartz D. Smoking and leukocyte counts. Results of an epidemiological survey. Lancet 1971;2:632-4.
9. Nieto FJ, Szklo M, Folsom AR, Rock R, Mercuri M. Leukocyte count correlates in middle-aged adults: the Atherosclerotic Risk in Communities (ARIC) Study. Am J Epidemiol 1992;156:525-37.
10. Friedman GD, Tekawa I, Grimm RH, Manolio T, Shannon SG, Sidney S. The leucocyte count: correlates and relationship to coronary risk factors: the CARDIA study. Int J Epidemiol 1990;19:889-93.
11. Lowe GD, Machado SG, Krol WF, Barton BA, Forbes CD. White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. Thromb Haemost 1985;54:700-3.
12. Hansen LK, Grimm RH Jr, Neaton JD. The relationship of white blood cell count to other cardiovascular risk factors. Int J Epidemiol 1990;19:881-8.
13. Welch GN, Loscalzo J. Homocysteine and atherosclerosis. N Engl J Med 1998;338:1042-50.
14. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001;38:263-355.
15. Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem 1995;41:991-4.
16. Hackam DG, Peterson JC, Spence JD. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 μmol/l. Am J Hypertens 2000;13:105-10.
17. Folsom AR, Desvarieux M, Nieto FJ, Boland LL, Ballantyne CM, Chambless LE. B vitamin status and inflammatory markers. Atherosclerosis 2003;169:169-74.
18. Saito I, Folsom AR, Brancati FL, Duncan BB, Chambless LE, McGovern PG. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Intern Med 2000;133:81-91.
19. Dawson H, Collins G, Pyle R, Deep-Dixit V, Taub DD. The immunoregulatory effects of homocysteine and its intermediates on T-lymphocyte function. Mech Ageing Dev 2004;125:107-10.
20. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 2003;169:203-14.
21. Hoffman M, Blum A, Baruch R, Kaplan E, Benjamin M. Leukocytes and coronary heart disease. Atherosclerosis 2004;172:1-6.
22. Wang G, Woo CW, Sung FL, Siow YL, O K. Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: role of chemokine and adhesion molecules. Arterioscler Thromb Vasc Biol 2002;22:1777-83.
23. Holven KB, Aukrust P, Holm T, Ose L, Nenseter MS. Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects. Arterioscler Thromb Vasc Biol 2002;22:699-703.
24. Poddar R, Sivasubramanian N, DiBello PM, Robinson K, Jacobson DW. Homocysteine induces expression and secretion of moncyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation 2001;103:2717-23.
25. Koga T, Claycombe K, Meydani M. Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells. Atherosclerosis 2002;161:365-74.
26. Zeng X, Dai J, Remick DG, Wang X. Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes. Circ Res 2003;93:311-20.
27. Dudman NP, Temple SE, Guo XW, Fu W, Perry MA. Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo. Circ Res 1999;84:409-16.
28. Rothenbacher D, Fischer HG, Hoffmeister A, Hoffmann MM, Marz W, Bode G, et al. Homocysteine and methylenetetrahydrofolate reductase genotype: association with risk of coronary heart disease and relation to inflammatory, hemostatic, and lipid parameters. Atherosclerosis 2002;162:193-200.